PDL BioPharma Inc (NASDAQ:PDLI) - Share price


Stock Report

PDL BioPharma Inc PDLI

Last Price
$2.46

Day Change
-0.07|-2.77%

As of 23/08/2019
16:00:05 EDT | USD
Minimum 15 Minutes Delay.

Last Close2.53
Day Range2.44 - 2.54
Mkt Cap280.90Mil
52-Wk Range2.25 - 3.89
Yield %-
ISINUS69329Y1047
Volume1,696,802
P/E8.48
P/S2.55
P/CF-176.98

Share Price

Financials
201620172018
More ...
Income Statement
Revenue213.90302.32195.77
Operating Income153.66176.3965.97
Net Income63.61110.75-68.86
Basic EPS0.390.71-0.47
Avg. Diluted Shares Outstanding164156146
Balance Sheet
Current Assets398.03640.44517.22
Non Current Assets817.36602.68446.52
Total Assets1,215.391,243.12963.74
Current Liabilities130.32193.1152.47
Total Liabilities459.96397.23233.96
Total Equity751.14845.89729.78
Cash Flow
Operating Cash Flow101.7240.62-13.43
Capital Expenditure-59.53-1.30-24.52
Free Cash Flow42.1939.33-37.95

In millions, except "Basic EPS". Currency is USD.

Company Profile

PDL BioPharma Inc is engaged in the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing value of its patent.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

107
Key Stats
More ...
Price/Earning TTM8.72
Price/Book0.43
Price/Sales TTM1.80
Rev Growth (3 year avg)-29.31
EPS Growth (3 year avg)-
Operating Margin % TTM33.70
Net Margin % TTM-35.17
ROE TTM-8.74
Debt/Equity0.17
Dividends
PreviousLatest
More ...
Declared Date01/02/1602/05/16
Ex-Div02/03/1602/06/16
Paid11/03/1613/06/16
Amnt0.050.05
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.